An ascending dose study to determine the safety and effect of antibodies against hepatitis B (The SAMBA Study)
Phase 1
- Conditions
- Chronic hepatitis B infectionMedDRA version: 20.1Level: PTClassification code: 10008910Term: Chronic hepatitis B Class: 100000004862Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Registration Number
- CTIS2023-508444-22-01
- Lead Sponsor
- Region Midtjylland
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method